State-of-the-Art PaperAnti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction
Under an Elsevier user license
open archive
Key Words
acute myocardial infarction
inflammation
ventricular remodeling
Abbreviations and Acronyms
AAT
alpha1-trypsin
AMI
acute myocardial infarction
COX
cyclooxygenase
CRP
C-reactive protein
CVF
cobra venom factor
HF
heart failure
IL
interleukin
IL-1R1
interleukin 1 receptor 1
IVIG
intravenous immunoglobulin
MACE
major adverse cardiac event(s)
MMP
metalloproteinase
PCI
percutaneous coronary intervention
PI3K
phosphoinositide 3-kinase
RCT
randomized clinical trial
STEMI
ST-segment elevation myocardial infarction
TNF
tumor necrosis factor
TNFR
tumor necrosis factor receptor
Cited by (0)
Drs. Abbate, Toldo, and Van Tassell are supported by research grants from the American Heart Association and the National Institutes of Health. Dr. Abbate has received research grants from Gilead, Novartis, and XOMA; has lectured for GlaxoSmithKline, Novartis, and XOMA; and has consulted for Gilead, Janssen, Omni Biopharma, Swedish Orphan Biovitrum, and XOMA. Dr. Van Tassell has received research grants from Gilead and Novartis; and has consulted for Novartis. Dr. Seropian has reported that he has no relationships relevant to the contents of this paper to disclose.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.